Is RAIN a good investment?
As of 2025-03-20, the Fair Value of Rain Therapeutics Inc (RAIN) is -2.25 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 2.18 USD, the upside of Rain Therapeutics Inc is -203.16%. This means that RAIN is not a good investment.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -21.08 | -51.39 | -75.72 | -0.44 | -37.16 | |
| YoY growth | -93.39% | -143.79% | -47.34% | 99.42% | -46.28% | |
| Market Cap (mil) | 16.55 |
| P/E | |
| Forward P/E |
| EPS | -0.45 |
| Avg earnings growth rate | -46.28% |
| TTM earnings | -3.41 |